Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation
- 5 July 2007
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 21 (12), 2540-2544
- https://doi.org/10.1038/sj.leu.2404828
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemiaBone Marrow Transplantation, 2005
- Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplantBone Marrow Transplantation, 2004
- Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantationBlood, 2004
- Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de Moelle (SFGM)British Journal of Haematology, 2000
- Leukemia: management of relapse after allogeneic bone marrow transplantation.Journal of Clinical Oncology, 1994
- Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.Journal of Clinical Oncology, 1989
- Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 casesBritish Journal of Haematology, 1988